Company Overview and News

 
U.S. to Review Gas Pipeline Policy for First Time Since 1999 - Bloomberg

10h bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
Upvote Downvote

 
What Could Impact Dominion Energy’s 1Q18 Earnings?

16h marketrealist
Analysts expect Richmond-based Dominion Energy (D) to report earnings of $1.06 per share for the quarter ended on March 31, 2018. In the comparable quarter last year, it reported earnings of $0.97 per share. The estimates represent an increase of more than 9% in its per-share earnings year-over-year.
Upvote Downvote

 
U.S. Set to Edge China Out in the Solar Race

17h zacks
As solar energy keeps getting cheaper by the day, countries across the globe are fast adapting to the clean energy source to fulfil all energy needs. Countries like China have stepped up their game by investing significantly in cutting-edge technologies related to solar energy. As a matter of fact, China has also surpassed the United States when it comes to investing in clean energy. This has led to speculation about the future of solar energy in the United States and whether it would lose to China in the solar race.
Upvote Downvote

 
A Look at NextEra Energy’s Earnings Drivers and Growth Prospects

19h marketrealist
Analysts expect Florida-based NextEra Energy (NEE) to report earnings per share (or EPS) of $1.82 for 1Q18. In 1Q17, it reported EPS of $1.75. Renewables giant NextEra Energy is one of the fastest-growing utilities in the sector. In 2017, its adjusted EPS grew more than 8.0% compared to 2016. The broader utilities’ (XLU) (IDU) earnings growth rate is ~4.0%–6.0%.
Upvote Downvote

 
How NextEra Energy Is Placed ahead of Its 1Q18 Earnings

2018-04-18 marketrealist
The biggest utility by market capitalization, NextEra Energy (NEE) plans to report its 1Q18 financial results on April 24, 2018. According to analysts, NextEra Energy is estimated to report total revenues of ~$4.2 billion for 1Q18. In 1Q17, it reported revenues of ~4.0 billion, indicating year-over-year revenue growth of around 5.0%.
Upvote Downvote

 
Southern Company’s Payout Ratio Compared to Its Peers

2018-04-18 marketrealist
Let’s take a look at Southern Company’s payout ratio. A payout ratio indicates a portion of a company’s profits distributed to shareholders in the form of dividends. In 2017, Southern Company’s payout ratio was 76%. We’ve adjusted SO’s earnings for extraordinary items, which included a $3.4 billion loss on the Kemper County power plant in 2017.
Upvote Downvote

 
Southern Company’s Dividend Growth Compared to Its Peers

2018-04-18 marketrealist
Although Southern Company’s (SO) dividend yield is higher than many of its peers, it significantly lags behind its peers in terms of dividend growth. Its dividends per share grew 3.4% compounded annually in the last five years. In comparison, the broader utilities (XLU) increased their dividends per share by 4% compounded annually in the same period.
Upvote Downvote

 
Southern Company Raised Dividend for 17th Consecutive Year

2018-04-18 marketrealist
Georgia-based Southern Company (SO) announced on April 16, 2018, that it has raised its quarterly dividend by $0.02 to $0.60 per share. In 2018, it’s expected to pay $2.38 per share, which is more than 3% higher than its total dividends per share last year. The ex-dividend date is May 18, 2018, and the dividend will be paid on June 6, 2018.
Upvote Downvote

 
Duke Energy to Provide $38M in Tax Savings to Customers

2018-04-17 zacks
Duke Energy Corp. (DUK - Free Report) will offer a notable $38 million in annual tax savings on electric and natural gas bills for its customers in Ohio and Kentucky, beginning from April and May 2018. The Tax Cuts and Jobs Act that came into effect on Jan 1, 2018, clearly led to this entire bill reduction. Details of Projected Tax Savings In particular, Duke Energy’s customers, residing in Ohio, would save approximately $20 million in annual tax on their electric bills.
Upvote Downvote

 
How FirstEnergy Stock Is Currently Valued

2018-04-17 marketrealist
FirstEnergy (FE) stock has soared more than 15% in the last three months, significantly outperforming broader utilities (XLU). Investment from activist hedge fund Elliott Management and improved earnings growth prospects boosted FE stock, which is currently trading at an EV-to-EBITDA (enterprise value to earnings before interest, tax, depreciation, and amortization) ratio of 8.4x, lower than its five-year average of ~9.
Upvote Downvote

 
A Look at FirstEnergy, Pre-1Q18 Earnings Release

2018-04-17 marketrealist
Ohio-based FirstEnergy (FE) is set to report its 1Q18 financial results on April 23, 2018. Wall Street analysts expect it to report EPS (earnings per share) of $0.67. In 1Q17, it had EPS of $0.78, implying that analysts expect FE’s EPS to fall 14% YoY (year-over-year).
Upvote Downvote

 
Utilities: Leaders and Laggards Last Week

2018-04-17 marketrealist
US utility stocks have been sluggish for the last few months. Utilities that are sensitive to the interest rate have been on a downward streak since December 2017 mainly due to tax reforms, rate hikes, and valuation concerns. Utilities continued their downtrend last week. The Utilities Select Sector SPDR ETF (XLU) fell more than 1%, while broader markets rose more than 2% during the week.
Upvote Downvote

 
Ormat's Unit to Build 40MW Storage, Increase Grid Resilience

2018-04-17 zacks
Ormat Technologies, Inc. (ORA - Free Report) announced that its subsidiary, Viridity Energy Solutions, Inc. will start the construction of two 20 megawatt (MW)/20MWh utility scale, in-front-of-the-meter battery energy storage systems (“BESS”) located in Plumsted Township and Alpha, NJ. The BESS will assist in balancing energy demand in the electricity grid and is expected to generate revenues in the range of $7-$8 million in 2019.
Upvote Downvote

 
Zacks.com highlights: US Foods Holding, Medifast, Marcus, Acushnet Holdings and Dine Brands Global

2018-04-17 zacks
Chicago, IL – April 17, 2018 - Stocks in this week’s article include: US Foods Holding Corp. (USFD - Free Report) , Medifast, Inc. (MED - Free Report) , The Marcus Corporation (MCS - Free Report) , Acushnet Holdings Corp. (GOLF - Free Report) and Dine Brands Global, Inc. (DIN - Free Report) .
Upvote Downvote

 
Zacks Investment Ideas feature highlights: Groupon

2018-04-17 zacks
Chicago, IL – April 17, 2018 – Today, Zacks Investment Ideas feature highlights Features: Groupon (GRPN - Free Report) .
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...

CUSIP: 65339F101